ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Natco Pharma jumps 4% on filing generic version of oncology drug in US
The drug major filed an abbreviated new drug application (ANDA) for generic versions of Olaparib tablets - 100 mg and 150 mg with the US Food and Drug Administration (USFDA)
Announcement as on 13 February 2023

Natco Pharma submits application with USFDA for generic cancer drug
The company has submitted an Abbreviated New Drug Application (ANDA) containing a 'paragraph IV' certification with the US Food and Drug Administration (FDA) for the product, a generic version of AstraZeneca's Olaparib tablets in strengths of 100mg and 150
Announcement as on 13 February 2023

Buy Natco Pharma; target of Rs 704: Geojit
Geojit is bullish on Natco Pharma has recommended buy rating on the stock with a target price of Rs 704 in its research report dated December 05, 2022.
Announcement as on 05 December 2022

Hold Natco Pharma; target of Rs 660: ICICI Direct
ICICI Direct recommended hold rating on Natco Pharma with a target price of Rs 660 in its research report dated November 17, 2022.
Announcement as on 18 November 2022

Natco Pharma gains after court waves through insecticide launch
Natco Pharma said it is the first company in India to have received registration approval from Central Insecticide Board Registration Committee for indigenous manufacture of chlorantraniliprole technical 93.00 percent w/w min.
Announcement as on 20 September 2022

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 917.61
  • 12Day Average: 919.33
  • 20Day Average: 925.31
  • 50Day Average: 917.99
  • 100Day Average: 1000.13
  • 150Day Average: 965.24
  • 200Day Average: 941.71

524816 Indicators & signals

Indicator MACD (12,26,9)

921.17, 928.7, -7.83
Indicator MACD is in negative zone

Indicator ADX (14)

6.62, 20.3, 17.78
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 48
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
14 Fri Aug 2026 902.40 885.75 to 962.25 -5.23% 3.6 times
13 Thu Aug 2026 952.25 917.60 to 960.40 4.07% 1.6 times
12 Wed Aug 2026 915.00 906.00 to 922.00 0.89% 0.47 times
11 Tue Aug 2026 906.90 903.55 to 929.40 -0.5% 0.75 times
10 Mon Aug 2026 911.50 905.55 to 932.00 -0.62% 0.72 times
07 Fri Aug 2026 917.15 912.00 to 921.10 0.53% 0.14 times
06 Thu Aug 2026 912.35 910.00 to 932.75 -0.58% 0.73 times
05 Wed Aug 2026 917.70 912.60 to 926.60 0.04% 3.47 times
04 Tue Aug 2026 917.30 913.80 to 930.45 -1.24% 0.93 times
03 Mon Aug 2026 928.80 917.10 to 939.00 0.97% 0.8 times
31 Fri Jul 2026 919.85 914.00 to 936.15 -1.17% 0.41 times
30 Thu Jul 2026 930.70 926.10 to 945.00 -0.52% 0.3 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top